EDCTP and CEPI funding moves IAVI’s Lassa fever vaccine candidate into advanced clinical development
NEW YORK, THE HAGUE, AND OSLO – JUNE 15, 2021 – IAVI has received an award of €22.8 million from the European & Developing Countries...
top of page
bottom of page